J&j To Spend Up To $200m On Ebola Vaccine Program

NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson will start safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus. The health care products maker says it has committed up to $200 million to speed up and expand production of a vaccine program being developed by its Janssen Pharmaceutical Companies. J&J is developing the vaccine with the Danish biotech company Bavarian Nordic.Read more on NewsOK.com

Topics:  brunswick   n.j ap     johnson   january   ebola   janssen pharmaceutical   companies   j&j   danish   bavarian   nordic   newsok    johnson   vaccine program   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News